INTRODUCTION
============

An outbreak of pneumonia of unknown etiology occurred in Wuhan, China in December 2019. A prompt investigation confirmed that the 2019 novel coronavirus disease (COVID-19; temporarily termed as 2019-nCoV) was responsible ([@B1]). Human-to-human transmission of COVID-19 was confirmed to be possible ([@B2]), and COVID-19 rapidly spread throughout China and to other countries. As of February 16, 2020, COVID-19 infections had been confirmed in 51857 patients globally, including 51174 patients in China and 683 patients outside China ([@B3]). The first COVID-19 patient was identified in South Korea (hereafter, Korea) on January 20, 2020. As of February 16, there were 29 COVID-19 patients in Korea, placing Korea in fifth place internationally in terms of the number of COVID-19 patients, after China, Singapore (72 patients), Japan (53 patients), and Thailand (34 patients). Deaths have almost exclusively occurred in China (1666 patients; 3.3%), rather than outside China (3 patients; 0.4%). The discrepancy in the death rate between China and other countries might be due to differences in the disease manifestation of COVID-19 pneumonia or in other countries\' capacity to manage a limited number of cases, in contrast to the overwhelming numbers of cases in China.

Early radiologic investigations consistently reported that the typical computed tomography (CT) findings of COVID-19 pneumonia were bilateral ground-glass opacities (GGOs) and consolidation with a peripheral and posterior lung distribution ([@B4][@B5][@B6]). The current publications on this topic are exclusively from China, and it remains unknown how COVID-19 pneumonia appears on chest radiographs and CT images of patients outside China. Therefore, we present a preliminary report on the chest radiographic and CT findings of COVID-19 pneumonia in Korea.

MATERIALS AND METHODS
=====================

This retrospective study was approved by the Institutional Review Board of the participating hospitals, and the requirement for informed consent was waived.

Patients
--------

On February 6, 2020, the Korean Society of Thoracic Radiology proposed a multi-institutional collaboration for reporting the radiologic findings of COVID-19. Seven members with different affiliations decided to participate in this study, and the working group submitted a document for review by the Institutional Review Board of each affiliated hospital. Due to between-hospital differences in the required period for Institutional Review Board review, we expedited the process to report cases for which approval was received, while excluding cases under review. Consequently, we included nine consecutive patients (median age, 54 years; four men and five women) with COVID-19 infections confirmed through a pan-coronavirus conventional polymerase chain reaction assay from January 2020 through February 9, 2020 from Incheon Medical Center ([@B7]), Seoul National University Hospital, and Seoul National University Bundang Hospital.

CT Protocol
-----------

All CT examinations were performed using a multi-detector CT scanner with 64 or more channels (Somatom Definition, Somatom Definition AS+, or Somatom Force, Siemens Healthineers, Erlangen, Germany). The detailed parameters for CT acquisition were as follows: tube voltage, 120 kVp; tube current, standard (reference mAs, 60--120) to low-dose (reference mAs, 30) with automatic exposure control; slice thickness, 1.0 mm; reconstruction interval, 1.0--3.0 mm; and a sharp reconstruction kernel. CT images were obtained with the patient in the supine position at full inspiration and without contrast medium.

All patients underwent a baseline digital anteroposterior chest radiography at full inspiration using a mobile chest radiograph machine (FLUOROSPOT Compact FD, Siemens Healthineers; DRX-Revolution Mobile X-ray System, Carestream Health, Rochester, NY, USA; or Optima XR220, GE Healthcare, Milwaukee, WI, USA).

Eight of the nine patients had parenchymal abnormalities on their baseline chest CT scans. In another patient, the baseline chest CT scan was normal, and parenchymal abnormalities were observed on a follow-up CT scan one week later. Accordingly, we analyzed eight baseline chest CT scans and one follow-up CT scan with abnormal findings of COVID-19 pneumonia.

Image Analysis
--------------

Two attending radiologists (with 15 and 12 years of experience in chest imaging, respectively) reviewed the chest radiographs and CT images by consensus on a picture archiving and communication system (PACS, INFINITT Healthcare co., Ltd., Seoul, Korea). The readers assessed the presence, location, and density of parenchymal abnormalities on chest radiographs without reviewing the CT images, and graded the abnormalities using the following 5-point scale ([@B8]): 1, normal; 2, patchy atelectasis and/or hyperinflation and/or bronchial wall thickening; 3, focal alveolar consolidation involving no more than one segment or one lobe; 4, multifocal consolidation; and 5, diffuse alveolar consolidation. After the initial assessment of the chest radiographs, we checked whether the abnormalities on chest radiographs corresponded to abnormalities on chest CT images.

The CT images were evaluated with both lung (width, 1500 HU; level, −600 HU) and mediastinal (width, 400 HU; level, 40 HU) window settings. The readers identified all separate pulmonary lesions on CT and analyzed the longest diameter, location, shape, density, and margin of the lesions. The locations of the lesions were specified as lobar, axial, and anteroposterior. For the axial location, the peripheral lung was defined as the outer one-third of the lung, and the central lung was defined as the inner two-thirds of the lung. According to a horizontal line dividing the lung into anterior and posterior halves, locations were classified as anterior or posterior. The shapes of the lesions were first categorized as patchy, confluent, or nodular. Patchy lesions were defined as isolated focal lesions with no nodular shape in the segment, and confluent lesions were defined as large fused lesions involving multiple segments. The densities of the patchy to confluent lesions were classified as pure GGO, mixed GGO and consolidation, consolidation, or a crazy-paving appearance. The densities of the nodular lesions were classified as pure GGO, part-solid, or solid. The margins of the lesions were dichotomized as ill-defined or well-defined. We evaluated whether the pulmonary lesions had a predilection for the lower lobes, pleura, or bronchovascular bundles. Furthermore, the readers evaluated the presence of air-bronchograms, the reversed halo sign, cavities, micronodules, a tree-in-bud appearance, and pleural effusion based on the Fleischner Society glossary of terms for thoracic imaging ([@B9]).

Statistical Analysis
--------------------

Fisher\'s exact test was used to compare patchy to confluent lesions and nodular lesions in terms of the proportion of pure GGO lesions, axial location, anteroposterior location, margin, and predilection for the lower lobes, pleura, and bronchovascular bundles. Statistical analyses were performed using SPSS version 25.0 (IBM Corp., Armonk, NY, USA). *P* values \< 0.05 were considered to indicate a statistically significant difference.

RESULTS
=======

Baseline Chest Radiographic Findings
------------------------------------

Five of the nine patients showed radiographic abnormalities (severity grade 2, one patient; grade 3, two patients; and grades 4 and 5, one patient each). Chest CT scans revealed that the grade 2 lesion and one of the grade 3 lesions as areas of prominent breast tissue mimicking faint GGO and post-inflammatory focal atelectasis on chest radiography, respectively. In summary, three of the nine patients (33.3%) were confirmed to have parenchymal abnormalities related to COVID-19 pneumonia on chest radiographs ([Figs. 1A](#F1){ref-type="fig"}, [2A](#F2){ref-type="fig"}, [3A](#F3){ref-type="fig"}).

One of the three patients had a single nodular opacity in the left lower lung zone ([Fig. 3A](#F3){ref-type="fig"}), and the other two patients had four and five patchy opacities in both lungs ([Figs. 1A](#F1){ref-type="fig"}, [2A](#F2){ref-type="fig"}), respectively ([Table 1](#T1){ref-type="table"}). In a per-lesion analysis, 50% of the 10 opacities presented in the lower lung zones, 80% of the opacities were located in the peripheral lungs, and 70% of the opacities were areas of consolidation.

Chest CT Findings
-----------------

In total, 77 lung parenchymal lesions were identified in the nine patients, of whom eight had bilateral lung parenchymal abnormalities. The median numbers of parenchymal lesions and involved lobes were 5 (interquartile range, 2--13) and 2 (interquartile range, 2--5), respectively. The most frequently involved lobe was the right lower lobe (eight patients), followed by the left upper and lower lobes (six patients each). Among the 77 identified lesions, 39% were patchy, 13% were confluent, and 48% were nodular ([Table 2](#T2){ref-type="table"}). The average diameters of the patchy, confluent, and nodular lesions were 2.6 ± 1.5 cm, 9.8 ± 2.6 cm, and 1.3 ± 0.6 cm, respectively. The peripheral and posterior lung were involved in 78% and 67% of the lesions, respectively. Patchy to confluent lesions were more prevalent than nodular lesions per patient (median relative proportion of patchy to confluent lesions, 86% \[interquartile range, 33--100%\]).

Patchy to confluent lesions primarily manifested as mixed GGO and consolidative lesions (50%) ([Fig. 1B, C](#F1){ref-type="fig"}), followed by pure GGO lesions (35%) ([Fig. 2B, C](#F2){ref-type="fig"}), lesions with a crazy-paving appearance (10%), and areas of consolidation (5%). The most frequent shape of the lesions was wedge-shaped (42%), followed by elongated (33%) and confluent (25%). They frequently had an ill-defined margin (70%) and 28% of the lesions had an air-bronchogram. Nodular lesions primarily manifested as pure GGO lesions (57%), followed by predominantly GGO lesions (32%) and predominantly solid lesions (11%). Nodular lesions were round (95%) and had ill-defined margins (75%). There were no cavities, micronodules, lesions with a tree-in-bud appearance, or pleural effusions. Compared to nodular lesions, patchy to confluent lesions were primarily distributed along the pleura (80% vs. 35%; *p* \< 0.001) and more commonly involved the lower lobes (60% vs. 35%; *p* = 0.040) ([Fig. 4A](#F4){ref-type="fig"}). The nodular lesions were primarily distributed along the bronchovascular bundles (59% vs. 28%; *p* = 0.006) ([Fig. 4B](#F4){ref-type="fig"}) and tended to manifest as pure GGO lesions (57% vs. 35%; *p* = 0.069).

DISCUSSION
==========

The outbreak of COVID-19 pneumonia has resulted in a global health emergency, similar to the outbreaks of severe acute respiratory syndrome (SARS) in 2003 and Middle East respiratory syndrome (MERS) in 2012, both of which were also caused by viruses belonging to the family *coronaviridae*. Indeed, COVID-19 pneumonia shows radiologic similarities to SARS and MERS pneumonia ([@B10][@B11][@B12][@B13][@B14]), with a predominance of bilateral GGO and consolidative lesions in the peripheral lung. Despite the similarities in CT findings, COVID-19 pneumonia seems radiologically milder than SARS and MERS pneumonia. The proportion of patients with abnormal initial radiographic findings was 78.3--82.4% in SARS ([@B15][@B16]) and 83.6% in MERS ([@B17]), but only 33% in our cases of COVID-19 pneumonia. GGO lesions on CT without any consolidation presented in 45% of our cases and in 45--67% of Chinese COVID-19 patients ([@B4][@B5]), in 14--40% of MERS patients ([@B10][@B11]), and in 50% of SARS patients ([@B12]).

The CT findings of COVID-19 pneumonia in Korea were generally consistent with those of COVID-19 pneumonia in China ([@B4][@B5][@B6][@B18]). However, the proportion of predominantly consolidative lesions in Chinese patients was approximately 30% ([@B4]) to 60% ([@B5]), but the Korean patients did not have predominantly consolidative lesions. Furthermore, the proportion of chest radiographic abnormalities was 60% in Chinese COVID-19 patients ([@B19]), but 33% in Korean patients. Considering these radiologic observations and the lack of deaths from COVID-19 in Korea, Korean patients seem to experience a milder disease course than Chinese patients.

Interestingly, we observed a reversed halo sign in one patient ([Fig. 3B](#F3){ref-type="fig"}), and a few similar cases have been reported in recent reports ([@B19][@B20][@B21]). The reversed halo sign was first regarded as specific for cryptogenic organizing pneumonia, and it can be seen in various infectious diseases, including angioinvasive pulmonary aspergillosis or mucormycosis, paracoccidioidomycosis, *pneumocystis jiroveci* pneumonia, and tuberculosis ([@B22]). This sign might reflect an organizing pneumonia pattern in COVID-19 pneumonia ([@B21]).

A few limitations exist in this study. First, the number of included patients was small, and the included patients only accounted for approximately one-third of all 29 identified patients of COVID-19 in Korea as of February 16, 2020. Including more patients would enable a more comprehensive description of the radiologic findings of COVID-19. However, we weighed this consideration against the importance of urgent reporting. Second, we focused on baseline CT findings that clinicians and radiologists first encountered, rather than findings from follow-up CT scans, as follow-up CT scans were performed in few patients. Third, we minimized the clinical information of the patients, as a substantial proportion of the included patients were receiving inpatient treatment at the time of the analysis.

In conclusion, COVID-19 pneumonia in Korea generally manifested as pure GGO to mixed GGO and consolidative lesions in the bilateral peripheral posterior lungs. The shape of the lesions was typically ill-defined and patchy to confluent, or nodular. Patchy to confluent lesions were primarily distributed along the pleura, whereas nodular lesions were mainly distributed along the bronchovascular bundles. Most of the pulmonary lesions were ambiguous on chest radiographs. Clinicians and radiologists should become familiar with the CT findings of COVID-19 and the limitations of chest radiographs in evaluating pneumonia to manage the COVID-19 outbreak.
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![Representative chest radiographic (A) and CT images (B, C) of COVID-19 pneumonia manifesting as confluent mixed ground-glass opacities and consolidation on CT.\
**A.** Anteroposterior chest radiograph shows multifocal patchy peripheral consolidations in bilateral lungs, except for left upper lung zone. **B, C.** Coronal and axial chest CT images show confluent mixed ground-glass opacities and consolidative lesions in peripheral bilateral lungs. Discrete patchy consolidation (arrowheads) is noted in left upper lobe. On axial CT image **(C)**, confluent lesions are mainly distributed in peripheral lung along bronchovascular bundles. Most of lesions spare juxtapleural area, and minor proportion of lesions touch pleura. Lesions contain multiple air-bronchograms, and air-bronchogram in superior segment of right lower lobe is distorted (arrows). COVID-19 = Coronavirus disease 2019, CT = computed tomography](kjr-21-494-g001){#F1}

![Representative chest radiographic (A) and CT images (B, C) of COVID-19 pneumonia manifesting as confluent pure ground-glass opacities on CT.\
**A.** Baseline anteroposterior chest radiograph shows patchy ground-glass opacities in right upper and lower lung zones and patchy consolidation in left middle to lower lung zones. Several calcified granulomas are incidentally noted in left upper lung zone. **B, C.** Baseline axial and coronal chest CT images show confluent pure ground-glass opacities involving both lungs. Most of confluent and patchy ground-glass opacities about pleura and fissure in peripheral lung. A few calcified granulomas are incidentally noted in left upper lobe.](kjr-21-494-g002){#F2}

![Representative chest radiographic (A) and CT images (B) of COVID-19 pneumonia manifesting as single nodular lesion.\
**A.** Anteroposterior chest radiograph shows single nodular consolidation (arrows) in left lower lung zone. **B.** Coronal chest CT image taken on same day shows 2.3-cm ill-defined nodular lesion with reversed halo sign with thick rim in left lower lobe, abutting adjacent pleura.](kjr-21-494-g003){#F3}

![Representative CT images (A, B) of COVID-19 pneumonia manifesting as radiograph-negative multiple patchy to nodular mixed ground-glass opacities and consolidations.\
**A.** Axial chest CT image shows ill-defined mixed ground-glass opacities and consolidative lesions with patchy and elongated shape (arrows) touching pleura in superior segment of right lower lobe. **B.** Axial chest CT image shows ill-defined part-solid nodules (arrows; mixed ground-glass opacities and solid nodules) along bronchovascular bundles in posterior segment of right upper lobe.](kjr-21-494-g004){#F4}

###### Per-Lesion Analysis of Chest Radiographic Findings

![](kjr-21-494-i001)

  Chest Radiographic Findings          n (%)
  ------------------------------------ --------
  Laterality                           
   Right lung                          5 (50)
   Left lung                           5 (50)
  Cephalocaudal distribution           
   Upper lung zone                     2 (20)
   Middle lung zone                    3 (30)
   Lower lung zone                     5 (50)
  Central to peripheral distribution   
   Central half                        2 (20)
   Peripheral half                     6 (60)
   Central and peripheral              2 (20)
  Shape                                
   Patchy                              9 (90)
   Nodular                             1 (10)
  Density                              
   Consolidation                       8 (80)
   Ground-glass lesion                 2 (20)

###### Per-Lesion Analysis of Chest Computed Tomography Findings

![](kjr-21-494-i002)

  Patchy to Confluent Lesions (n = 40)    n (%)     Nodular Lesions (n = 37)                n (%)
  --------------------------------------- --------- --------------------------------------- ---------
  Density                                           Density                                 
   Pure GGO                               14 (35)    Pure ground-glass                      21 (57)
   Mixed GGO and consolidation            20 (50)    Part-solid                             16 (43)
   Consolidation                          2 (5)      Solid                                  0 (0)
   Crazy-paving appearance                4 (10)                                            \-
  Axial location                                    Axial location                          
   Central                                1 (2)      Central                                7 (19)
   Peripheral                             30 (75)    Peripheral                             30 (81)
   Central and peripheral                 9 (23)                                            \-
  Anteroposterior location                          Anteroposterior location                
   Anterior                               9 (23)     Anterior                               13 (35)
   Posterior                              28 (70)    Posterior                              24 (65)
   Anterior and posterior                 3 (7)                                             \-
  Shape                                             Shape                                   
   Wedged                                 17 (42)    Round                                  35 (95)
   Elongated                              13 (33)    Elongated                              2 (5)
   Confluent                              10 (25)                                           \-
  Margin                                            Margin                                  
   Ill-defined                            28 (70)    Ill-defined                            28 (76)
   Well-defined                           12 (30)    Well-defined                           9 (24)
  Predilection for particular locations             Predilection for particular locations   
   Lower lobe involvement                 24 (60)    Lower lobe involvement                 13 (35)
   Pleural attachment                     32 (80)    Pleural attachment                     13 (35)
   Bronchovascular bundle                 11 (27)    Bronchovascular bundle                 22 (59)
  Internal characteristic findings                  Internal characteristic findings        
   Air-bronchogram                        11 (28)    Air-bronchogram                        5 (14)
                                          \-         Reversed halo sign                     1 (3)
                                          \-         Cavity                                 0 (0)

GGO = ground-glass opacity
